Cargando…
Comparing cancer drug approval systems in the United States and Japan
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170880/ https://www.ncbi.nlm.nih.gov/pubmed/37181668 http://dx.doi.org/10.1002/hsr2.1265 |
| _version_ | 1785039311411871744 |
|---|---|
| author | Kaneda, Yudai Maeda, Hideki Ozaki, Akihiko Higuchi, Yuka Tanimoto, Tetsuya |
| author_facet | Kaneda, Yudai Maeda, Hideki Ozaki, Akihiko Higuchi, Yuka Tanimoto, Tetsuya |
| author_sort | Kaneda, Yudai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10170880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101708802023-05-11 Comparing cancer drug approval systems in the United States and Japan Kaneda, Yudai Maeda, Hideki Ozaki, Akihiko Higuchi, Yuka Tanimoto, Tetsuya Health Sci Rep Letter to the Editor John Wiley and Sons Inc. 2023-05-10 /pmc/articles/PMC10170880/ /pubmed/37181668 http://dx.doi.org/10.1002/hsr2.1265 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letter to the Editor Kaneda, Yudai Maeda, Hideki Ozaki, Akihiko Higuchi, Yuka Tanimoto, Tetsuya Comparing cancer drug approval systems in the United States and Japan |
| title | Comparing cancer drug approval systems in the United States and Japan |
| title_full | Comparing cancer drug approval systems in the United States and Japan |
| title_fullStr | Comparing cancer drug approval systems in the United States and Japan |
| title_full_unstemmed | Comparing cancer drug approval systems in the United States and Japan |
| title_short | Comparing cancer drug approval systems in the United States and Japan |
| title_sort | comparing cancer drug approval systems in the united states and japan |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170880/ https://www.ncbi.nlm.nih.gov/pubmed/37181668 http://dx.doi.org/10.1002/hsr2.1265 |
| work_keys_str_mv | AT kanedayudai comparingcancerdrugapprovalsystemsintheunitedstatesandjapan AT maedahideki comparingcancerdrugapprovalsystemsintheunitedstatesandjapan AT ozakiakihiko comparingcancerdrugapprovalsystemsintheunitedstatesandjapan AT higuchiyuka comparingcancerdrugapprovalsystemsintheunitedstatesandjapan AT tanimototetsuya comparingcancerdrugapprovalsystemsintheunitedstatesandjapan |